These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 1091351)

  • 1. Electrophysiological effects of the antiarrhythmic agent QX-572 in the human heart with special reference to rate-induced changes in effective refractory periods.
    Rydén L; Olsson B; Kvasnicka J
    Cardiovasc Res; 1975 Jan; 9(1):81-94. PubMed ID: 1091351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes of refractory periods in the A-V conduction system induced by antiarrhythmic drugs. A study using His bundle recordings.
    Schlepper M; Neuss H
    Acta Cardiol; 1974; Suppl 18():269-77. PubMed ID: 4547475
    [No Abstract]   [Full Text] [Related]  

  • 3. Electrophysiological evaluation of disopyramide in man.
    Josephson ME; Caracta AR; Lau SH; Gallagher JJ; Damato AN
    Am Heart J; 1973 Dec; 86(6):771-80. PubMed ID: 4757788
    [No Abstract]   [Full Text] [Related]  

  • 4. Prolongation of cardiac refractory times in man by clofilium phosphate, a new antiarrhythmic agent.
    Greene HL; Werner JA; Gross BW; Sears GK; Trobaugh GB; Cobb LA
    Am Heart J; 1983 Sep; 106(3):492-501. PubMed ID: 6881021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiology of atropine.
    Bissett JK; de Soyza ND; Kane JJ; Murphy ML
    Cardiovasc Res; 1975 Jan; 9(1):73-80. PubMed ID: 804352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodynamic effects of the antiarrhythmic quaternary ammonium compound QX-572 in man.
    Rydén L; Hjalmarson A ; Kvasnicka J; Liander B
    Br Heart J; 1975 Jan; 37(1):65-73. PubMed ID: 1089426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiological effects of MS-551 in humans: a class III antiarrhythmic agent.
    Isomoto S; Konoe A; Centurion OA; Hayano M; Kaibara M; Hirata T; Yano K
    Pacing Clin Electrophysiol; 1995 Nov; 18(11):2022-7. PubMed ID: 8552516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of lidocaine on refractory periods in man.
    Josephson ME; Caracta AR; Lau SH; Gallagher JJ; Damato AN
    Am Heart J; 1972 Dec; 84(6):778-86. PubMed ID: 4669900
    [No Abstract]   [Full Text] [Related]  

  • 9. The electrophysiological effects of dicentrine on the conduction system of rabbit heart.
    Young ML; Su MJ; Wu MH; Chen CC
    Br J Pharmacol; 1994 Sep; 113(1):69-76. PubMed ID: 7812635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a new antiarrhythmic drug.
    Rydén L
    Acta Med Scand Suppl; 1974; 569():1-40. PubMed ID: 4533723
    [No Abstract]   [Full Text] [Related]  

  • 11. Dual effect of disopyramide on atrial and atrioventricular conduction and refractory periods.
    Birkhead JS; Vaughan Williams EM
    Br Heart J; 1977 Jun; 39(6):657-60. PubMed ID: 884018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a long-acting antiarrhythmic agent--QX-572--on therapy resistant ventricular tachyarrhythmias.
    Rydén L; Hjalmarson A; Wasir H; Werkö L
    Br Heart J; 1974 Aug; 36(8):811-21. PubMed ID: 4413111
    [No Abstract]   [Full Text] [Related]  

  • 13. Electrophysiologic evaluation of intravenous L-propionylcarnitine in man.
    Di Biase M; Tritto M; Pitzalis MV; Favale S; Rizzon P
    Int J Cardiol; 1991 Mar; 30(3):329-33. PubMed ID: 2055673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiologic effects of bepridil in the anesthetized dog studied by endocardiac electrodes.
    Sassine A; Masse C; Fajuri A; Hirsch JL; Labrid C; Puech P
    Am J Cardiol; 1984 Jun; 53(11):1707-11. PubMed ID: 6610347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Electrophysiologic basis of the anti-arrhythmic action of amiodarone in man].
    Touboul P; Huerta F; Porte J; Delahaye JP
    Arch Mal Coeur Vaiss; 1976 Aug; 69(8):845-53. PubMed ID: 823922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventricular and atrial electrophysiological effects of a IC antiarrhythmic drug, cibenzoline, in the innervated dog heart. Role of sodium and calcium channels.
    Timour Q; Aupetit JF; Loufoua-Moundanga J; Bertrix L; Freysz M; Faucon G
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Sep; 340(3):338-44. PubMed ID: 2554155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacology of N,N-bis(phenylcarbamolymethyl)dimethylammonium chloride (QX-572), a new antiarrhythmic agent.
    Schwartz ML; Stapleton J; Covino BG
    J Clin Pharmacol J New Drugs; 1967; 7(5):278-86. PubMed ID: 5237375
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical electrophysiological effects of intravenous recainam: an antiarrhythmic drug under investigation for the treatment of ventricular and supraventricular arrhythmias.
    Feld GK; Luceri RM; Greenspon AJ; Singh BN; Horowitz LN; Capuzzi DM; Frame VB; Myerburg RJ
    Pacing Clin Electrophysiol; 1991 Jul; 14(7):1129-37. PubMed ID: 1715550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of ritmilen on myocardial refractility and cardiac impulse conduction in patients with paroxysmal tachycardia].
    Grishkin IuN
    Kardiologiia; 1991 May; 31(5):40-4. PubMed ID: 1895645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of perhexiline maleate on the refractory periods of isolated atrial muscle and atrioventricular node of the rabbit.
    Yokoyama S; Konishi T; Matsuyama E; Matsuda H; Tamamura T; Kawai C
    J Cardiovasc Pharmacol; 1982; 4(1):26-31. PubMed ID: 6176795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.